Home › Funds › Carnegie Investment Counsel › JNJ

Carnegie Investment Counsel position in JNJ

JOHNSON & JOHNSON · Health Care

Carnegie Investment Counsel reported holding 126,462 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$33.5M, representing 0.67% of its reported portfolio and ranking #37 among its reported holdings. Carnegie Investment Counsel has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)126.46K sh
Reported value held$33.48M
Portfolio Weight0.67%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carnegie Investment Counsel's JNJ position evolved

Carnegie Investment Counsel first disclosed a stake in JNJ in Q3 2023 at 177,876 shares (US$27.7M). The position peaked in Q2 2026 at 132,112 shares, worth US$33.6M. Across 13 filings, Carnegie Investment Counsel increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 126,462 shares valued at US$33.5M — a reduction of -5,650 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 177.88K $27.70M New
Q4 2023 168.73K $26.45M Reduce
Q1 2024 160.65K $25.41M Reduce
Q2 2024 134.27K $19.63M Reduce
Q3 2024 133.83K $21.69M Hold
Q4 2024 128.66K $18.61M Reduce
Q1 2025 144.61K $22.34M Add
Q2 2025 141.57K $21.63M Reduce
Q3 2025 140.51K $26.05M Reduce
Q4 2025 160.09K $33.13M Add
Q1 2026 125.64K $30.71M Reduce
Q2 2026 132.11K $33.55M Add
Q3 2026 126.46K $33.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Carnegie Investment Counsel held JNJ?

Carnegie Investment Counsel has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Carnegie Investment Counsel's current position in JNJ?

As of Q3 2026, Carnegie Investment Counsel holds 126.46K shares of JNJ (JOHNSON & JOHNSON), valued at $33.48M, representing 0.67% of its reported portfolio and ranking #37.

Has Carnegie Investment Counsel been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Carnegie Investment Counsel reduced its position in JNJ. The position peaked in Q2 2026 at 132.11K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.